Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
Main Authors: | Belkıs Nihan Coşkun, Burcu Yağız, Seniha Gündüz Çorabay, Yavuz Pehlivan, Ediz Dalkılıç |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2022-04-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/anti-tnf-treatment-in-ankylosing-spondylitis-patients-with-chronic-kidney-disease-is-it-effective-and-safe-133459 |
Similar Items
-
Attitudes of patients with a rheumatic disease on drug use in the COVID-19 pandemic
by: Belkıs Nihan Coskun, et al.
Published: (2021-09-01) -
The usefulness and reliability of English-language YouTube videos as a source of knowledge for patients with familial Mediterranean fever
by: Belkıs Nihan Coşkun, et al.
Published: (2024-02-01) -
Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever
by: Tuğba Ocak, et al.
Published: (2024-03-01) -
Five Years’ Experience of Multidisciplinary Approach to Chronic Inflammatory Diseases by Rheumatology, Dermatology and Gastroenterology Departments
by: Burcu Yağız, et al.
Published: (2022-01-01) -
May The Neutrophil Lymphocyte Ratio be A New Marker For Uveitis Development In Ankylosing Spondylitis?
by: Zeynep Yılmaz Bozkurt, et al.
Published: (2021-03-01)